Assignee
AEGERION PHARMACEUTICALS INC
US·4 granted patents·4 pending applications·6 citations·filing 2013–2018
Top patents by PatentIndex Score
8 records- 0174US10213419B2Compound impurities and methods of detecting sameAEGERION PHARMACEUTICALS INC·Filed 2016·Granted Feb 26, 2019·3 cites·16 claims
- 0273US10087228B2Chimeric leptin polypeptide and method of using the sameAEGERION PHARMACEUTICALS INC·Filed 2015·Granted Oct 2, 2018·1 cites·7 claims
- 0370US10775386B2Methods of detecting anti-leptin neutralizing antibodiesAEGERION PHARMACEUTICALS INC·Filed 2017·Granted Sep 15, 2020·1 cites·19 claims
- 0470US9879063B2Engineered polypeptides having enhanced duration of action and reduced immunogenicityAEGERION PHARMACEUTICALS INC·Filed 2015·Granted Jan 30, 2018·1 cites·14 claims
- 0555US2015182515A1Methods for treating obesity and disorders associated with hyperlipidemia in a mammalAEGERION PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0654US2016137709A1Engineered polypeptides having enhanced duration of actionAEGERION PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0752US2014148476A1Methods for treating obesity and disorders associated with hyperlipidemia in a mammalAEGERION PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0852US2018305430A1Engineered Polypeptides Having Enhanced Duration of Action and Reduced ImmunogenicityAEGERION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →